ABSTRACT
Student nurses in a transatlantic exchange program explored the role of registered nurses in five countries' public health systems. The Ottawa Charter provided a framework for students to examine the nurse's responsibilities in public health. Students took practice placements in geographically rural a reason another continent and explored inequalities in health care. If nurses are to understand their role in the health care system then they must be taught the scope of their practice including their role in health promotion,public health practice and community development. For this project nursing instructors developed an assignment relevant to the aims and suitable for students in all five nursing programs. Only three of 48 students offered an assignment which focused on building healthy public policy. Nurse educators need to explore this further to ensure nurses of the future are aware of their role and responsibilities in this area and have skills to work effectively to influence and build healthy policy. The international student exchange supported the students' developing understanding of the breadth of initiatives around the globe where nurses are actively engaged in addressing inequalities of health. Findings from an analysis of their assignments are presented in this evaluative report.
Subject(s)
Education, Nursing/methods , Health Status Disparities , International Educational Exchange , Nurse's Role , Students, Nursing , Curriculum , Education, Nursing/trends , Faculty, Nursing , Health Policy , Health Promotion , Humans , Ontario , Public Health Nursing , Public Health Practice , Rural Health Services , SwedenSubject(s)
DNA-Binding Proteins/genetics , Gene Rearrangement , Proto-Oncogenes , Transcription Factors/genetics , Base Sequence , Female , Fetal Diseases , Histone-Lysine N-Methyltransferase , Humans , Infant , Leukemia, Monocytic, Acute/diagnosis , Leukemia, Monocytic, Acute/genetics , Male , Myeloid-Lymphoid Leukemia Protein , Pregnancy , Remission InductionABSTRACT
Protein kinase D (PKD) is a serine/threonine kinase regulated by diacylglycerol signaling pathways with unique domain composition and enzymatic properties, still awaiting identification of its specific substrate(s). Here we have isolated, cloned, and characterized a novel protein from PC12 cells, termed Kidins220 (kinase D-interacting substrate of 220 kDa), as the first identified PKD physiological substrate. Kidins220 contains 11 ankyrin repeats and four transmembrane domains within the N-terminal region. We have shown that Kidins220 is an integral membrane protein selectively expressed in brain and neuroendocrine cells, where it concentrates at the tip of neurites. In PC12 cells, PKD co-immunoprecipitates and phosphorylates endogenous Kidins220. This phosphorylation is increased after stimulating PKD activity in vivo by phorbol-12, 13-dibutyrate treatment. A constitutively active PKD mutant (PKD-S744E/S748E) phosphorylates recombinant Kindins220-VSVG in vitro in the absence of phorbol-12,13-dibutyrate. Conversely, Kidins220-VSVG phosphorylation is abolished when a dominant negative mutant of PKD (PKD-D733A) is used. Moreover, a peptide within the Kidins220 sequence, containing serine 919 in a consensus motif for PKD-specific phosphorylation, behaved as the best peptide substrate to date. Substitution of serine 919 to alanine abrogated peptide phosphorylation. Furthermore, by generating an antibody recognizing Kidins220 phosphorylated on serine 919, we show that phorbol ester treatment causes the specific phosphorylation of this residue in PC12 cells in vivo. Our results provide the first physiological substrate for PKD and indicate that Kidins220 is phosphorylated by PKD at serine 919 in vivo.
Subject(s)
Membrane Proteins/metabolism , Phosphoproteins/metabolism , Protein Kinase C/metabolism , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , DNA, Complementary , Membrane Proteins/chemistry , Membrane Proteins/genetics , Molecular Sequence Data , PC12 Cells , Phorbol 12,13-Dibutyrate/pharmacology , Phosphoproteins/chemistry , Phosphoproteins/genetics , Phosphorylation , Rats , Substrate SpecificityABSTRACT
OBJECTIVE: To describe the development of telemedicine capabilities-application of remote consultation and diagnostic techniques-and to evaluate the feasibility and practicality of such clinical outreach to rural and underserved communities with limited telecommunications infrastructures. MATERIAL AND METHODS: In 1992, Mayo Foundation (Rochester, Minn, Jacksonville, Fla, and Scottsdale, Ariz), the National Aeronautics and Space Administration, and the Defense Advanced Research Projects Agency collaborated to create a complex network of fiberoptic landlines, video recording systems, satellite terminals, and specially developed data translators linking Mayo sites with other locations in the continental United States on an on-demand basis. The purpose was to transmit data via the asynchronous transfer mode (ATM) digital communications protocol over the Advanced Communications Technology Satellite. The links were intended to provide a conduit for transmission of data for patient-specific consultations between physicians, evaluation of medical imagery, and medical education for clinical staffs at remote sites. RESULTS: Low-data-rate (LDR) experiments went live late in 1993. Mayo Clinic Rochester successfully provided medical consultation and services to 2 small regional medical facilities. High-data-rate (HDR) experiments included studies of remote digital echocardiography, store-and-forward telemedicine, cardiac catheterization, and teleconsultation for congenital heart disease. These studies combined landline data transmission with use of the satellite. The complexity of the routing paths and network components, immaturity of available software, and inexperience with existing telecommunications caused significant study delays. CONCLUSIONS: These experiments demonstrated that next-generation satellite technology can provide batch and real-time imagery for telemedicine. The first-generation of the ATM and satellite network technology used in these experiments created several technical problems and inconveniences that should be overcome as the network infrastructure matures.
Subject(s)
Program Evaluation/methods , Satellite Communications , Telemedicine/standards , Feasibility Studies , Humans , Medically Underserved Area , Remote Consultation/standards , Rural Health Services , United StatesABSTRACT
Clinical studies conducted with carvedilol suggest that beta-adrenoceptor antagonism is an effective therapeutic approach to the treatment of heart failure. However, many beta-adrenoceptor antagonists are weak partial agonists and possess significant intrinsic sympathomimetic activity (ISA), which may be problematic in the treatment of heart failure. In the present study, the ISAs of bucindolol, xamoterol, bisoprolol, and carvedilol were evaluated and compared in normal rats [Sprague-Dawley (SD)], in rats with confirmed heart failure [spontaneously hypertensive heart failure (SHHF)], and in isolated neonatal rat cardiomyocytes. At equieffective beta1-adrenolytic doses, the administration of xamoterol and bucindolol produced a prolonged, equieffective, and dose-related increase in heart rate in both pithed SD rats (ED50 = 5 and 40 microgram/kg, respectively) and SHHF rats (ED50 = 6 and 30 microgram/kg, respectively). The maximum effect of both compounds in SHHF rats was approximately 50% of that observed in SD rats. In contrast, carvedilol and bisoprolol had no significant effect on resting heart rate in the pithed SD or SHHF rat. The maximum increase in heart rate elicited by xamoterol and bucindolol was inhibited by treatment with propranolol, carvedilol, and betaxolol (beta1-adrenoceptor antagonist) but not by ICI 118551 (beta2-adrenoceptor antagonist) in neonatal rat. When the beta-adrenoceptor-mediated cAMP response was examined in cardiomyocytes, an identical partial agonist/antagonist response profile was observed for all compounds, demonstrating a strong correlation with the in vivo results. In contrast, GTP-sensitive ligand binding and tissue adenylate cyclase activity were not sensitive methods for detecting beta-adrenoceptor partial agonist activity in the heart. In summary, xamoterol and bucindolol, but not carvedilol and bisoprolol, exhibited direct beta1-adrenoceptor-mediated ISA in normal and heart failure rats.
Subject(s)
Adrenergic beta-Antagonists/pharmacology , Heart Failure/physiopathology , Heart Rate/drug effects , Adrenergic beta-Agonists/pharmacology , Animals , Animals, Newborn , Bisoprolol/pharmacology , Carbazoles/pharmacology , Carvedilol , Cell Membrane/metabolism , Cells, Cultured , Cyclic AMP/metabolism , Decerebrate State , Dose-Response Relationship, Drug , Heart Failure/metabolism , Iodocyanopindolol , Ligands , Male , Myocardium/metabolism , Propanolamines/pharmacology , Radioligand Assay , Rats , Rats, Sprague-Dawley , Xamoterol/pharmacologyABSTRACT
A high data rate terrestrial and satellite network was implemented to transfer medical images and data. This article describes the a optimization of the workstations and switching equipment incorporated into the network. Topics discussed in this article include tuning of the network software, the configuration of the Sun Microsystems workstations, the FORE Systems asynchronous transfer mode switches, as well as the throughput results of two telemedicine experiments undertaken by Mayo's physician staff. The technical staff was successful in achieving the data throughput needed by the telemedicine software; particularly important was the proper determination of peak throughput and TCP window sizes to ensure optimum use of the resources available on the Sun Microsystems and Hewlett Packard workstations.
Subject(s)
Computer Communication Networks , Image Processing, Computer-Assisted , Satellite Communications , Telemedicine , United States National Aeronautics and Space Administration , Angiography/instrumentation , Angiography/methods , Arizona , Evaluation Studies as Topic , Family Practice/instrumentation , Family Practice/methods , Minnesota , Spacecraft , Systems Integration , Technology Transfer , United StatesABSTRACT
The purpose of this study was to assess the Delphi technique as a viable method for forecasting future events in nursing education by determining the degree of accuracy of previously predicted events and identifying the circumstances that delayed or accelerated occurrence of the predicted events. Data were collected by three rounds of questionnaires distributed to 33 administrative heads of all nursing education programs in a southeastern state. The use of simple statistics concluded the Delphi technique was a valid instrument in nursing education planning: 22 of 26 events occurred as predicted, resulting in an 84.6% accuracy rate; 24 of 25 events which had not occurred remained viable, resulting in a 96% accuracy rate; 98.1% of the original events had either occurred or were still viable to occur.
Subject(s)
Curriculum , Delphi Technique , Education, Nursing/trends , Nursing Education Research/methods , Planning Techniques , Research Design , Education, Nursing, Associate , Education, Nursing, Baccalaureate , Education, Nursing, Diploma Programs , Faculty, Nursing , Forecasting , Humans , Nurse Administrators , Nursing, Practical/education , Reproducibility of Results , Southeastern United States , Surveys and QuestionnairesABSTRACT
Many beta-adrenoceptor antagonists are weak partial agonists, possessing significant intrinsic sympathomimetic activity (ISA). Under certain conditions, ISA may be deleterious through stimulation of beta 1- and/or beta 2-adrenoceptors in the heart. Drugs with ISA are particularly problematic in the treatment of congestive heart failure since agents that activate cardiac beta-adrenoceptors, such as xamoterol, have been associated with increases in the incidence of arrhythmia and mortality. Carvedilol was recently approved for the treatment of congestive heart failure, and bucindolol is currently in large clinical trials for this indication. In the present study, the ISA of bucindolol and carvedilol was evaluated in a standard model used to investigate ISA, the pithed rat. Both compounds produced dose-dependent inhibition of the positive-chronotropic effects of the non-selective beta-adrenoceptor agonist, isoproterenol, confirming that these drugs are beta-adrenoceptor antagonists. However, cumulative administration of bucindolol (10-1,000 micrograms/kg i.v.) in the pithed rat produced a significant dose-related increase in heart rate. The maximal increase in heart rate produced by bucindolol was 44% of that obtained with isoproterenol (90 +/- 6vs. 205 +/- 11 bpm, respectively). In marked contrast, cumulative administration of carvedilol (10-1,000 micrograms/kg i.v.) had no significant effect on resting heart rate in the pithed rat. The maximal increase in heart rate elicited by bucindolol (1,000 micrograms/kg i.v.) was inhibited by treatment with the competitive beta-adrenoceptor antagonist, propranolol (99 +/- 8.7 vs. 26 +/- 2.6 bpm), confirming that the ISA observed with bucindolol was mediated through stimulation of myocardial beta-adrenoceptors. Carvedilol, which had no ISA, antagonized the ISA of bucindolol, and was as effective as propranolol in blocking the ISA of bucindolol (99 +/- 8.7 vs. 27 +/- 2.3 bpm). In summary, bucindolol and carvedilol are both potent beta-adrenoceptor antagonists in the pithed rat: however, only bucindolol possesses beta-adrenoceptor-mediated ISA.
Subject(s)
Adrenergic beta-Antagonists/therapeutic use , Carbazoles/therapeutic use , Heart Failure/drug therapy , Propanolamines/therapeutic use , Sympathomimetics/therapeutic use , Adrenergic beta-Antagonists/adverse effects , Animals , Carbazoles/adverse effects , Carvedilol , Decerebrate State , Drug Evaluation, Preclinical , Evaluation Studies as Topic , Male , Propanolamines/adverse effects , Rats , Rats, Sprague-Dawley , Sympathomimetics/adverse effectsABSTRACT
It has been proposed that endothelin-1 (ET-1), a potent endogenous vasoactive peptide, may play an important role in the regulation of pulmonary blood flow. The purpose of the present study was to characterize the effects of ET-1 and a nonpeptide mixed ET(A) and ET(B) receptor antagonist, SB 209670, in isolated segments of the canine pulmonary artery and to examine the effects of SB 209670 in a canine model of acute hypoxia-induced pulmonary hypertension. In isolated segments of the pulmonary artery, SB 209670 (3-300 nM) produced a concentration-dependent antagonism of contraction elicited by ET-1 (pA2 = 8.9; slope = 0.9) and had no effect on phenylephrine responses. In addition, SB 209670 antagonized the small, endothelium-dependent relaxation induced by sarafotoxin 6c in phenylephrine (10 microM)-precontracted vessels (pKB = 8.6). In anesthetized dogs, the driving pressure across the pulmonary circulation increased approximately 100% during the hypoxic period (area under the curve [AUC] = 267.1 +/- 25.3 mm Hg x min). SB 209670 treatment (3 and 30 microg/kg/min i.v.) reduced pulmonary vascular resistance and produced a profound dose-related inhibition of hypoxia-induced pulmonary hypertension (AUC = 158.3 +/- 22.7 mm Hg x min and 50.1 +/- 4.9 mm Hg x min, respectively). None of the other hemodynamic or arterial blood gas parameters differed significantly in the vehicle and treatment groups. In addition, SB 209670 produced a significant reversal of hypoxia-induced pulmonary hypertension (AUC = 267.1 +/- 25.3 mm Hg x min vs. 167.8 +/- 23.4 mm Hg x min) when administered at the plateau of the hypoxic response. It was found that SB 209670 administration significantly elevated plasma levels of ET-1-LI (> or = 25-fold). These results suggest that ET-1 is an important mediator of hypoxia-induced pulmonary hypertension in the dog and that SB 209670, a potent and selective mixed ET(A) and ET(B)receptor antagonist in the pulmonary circulation, may represent an important therapeutic approach to the treatment of pulmonary hypertension.
Subject(s)
Endothelin Receptor Antagonists , Endothelin-1/pharmacology , Hypertension, Pulmonary/physiopathology , Hypoxia , Indans/pharmacology , Muscle Contraction/drug effects , Pulmonary Artery/drug effects , Animals , Blood Pressure , Dogs , Endothelin-1/physiology , Heart Rate , Hypertension, Pulmonary/drug therapy , Hypertension, Pulmonary/etiology , In Vitro Techniques , Male , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/physiology , Muscle, Smooth, Vascular/physiopathology , Phenylephrine/pharmacology , Pulmonary Artery/physiology , Pulmonary Artery/physiopathology , Vasoconstrictor Agents/pharmacology , Viper Venoms/pharmacologyABSTRACT
The Ig isotype switch from IgM to IgE is accompanied by a DNA recombination that joins S mu, the highly repetitive "switch" region upstream of the C mu gene, to the S epsilon region upstream of C epsilon, thereby creating a composite S mu-S epsilon region. In human B cells cultured in vitro with IL-4 to promote the switch to IgE, we previously described evidence for S mu-S gamma-S epsilon structures, suggesting that some B cells can switch sequentially from mu to gamma and then to epsilon; similar sequential switching to epsilon occurs routinely in the mouse. To identify which of the four human gamma genes might be involved in this mu-gamma-epsilon switching pathway, we cloned and analyzed nine S mu-S gamma-S epsilon composite switch regions and studied S epsilon-S gamma junctions from reciprocal deletion circles. Since only the S gamma 4 sequence had previously been described, our investigation required determination of the germline S gamma 1, S gamma 2, and S gamma 3 sequences. This analysis showed that S gamma 1 is the longest and most highly repetitive switch region, including nearly identical 79-bp repeats partially homologous to the 49-bp repeat of murine S gamma sequences. Of nine cloned chromosomal S mu-S gamma-S epsilon junctions, seven were derived from S gamma 1, and one each from S gamma 3 and S gamma 4 (both of which were in inverted orientation). Analysis of reciprocal S epsilon-S gamma junctions demonstrated contributions of S gamma 1, S gamma 2, and S gamma 4. Thus, all four of the human gamma loci can participate in sequential switching to IgE, arguing against a model of directed switching from a specific subtype, such as was proposed in the murine system.
Subject(s)
B-Lymphocytes/immunology , Immunoglobulin E/immunology , Immunoglobulin M/immunology , Repetitive Sequences, Nucleic Acid/genetics , Animals , B-Lymphocytes/drug effects , Base Sequence , Cells, Cultured , Cloning, Molecular , Humans , Immunoglobulin E/genetics , Immunoglobulin M/genetics , Interleukin-4/pharmacology , Mice , Molecular Sequence Data , Sequence Alignment , Sequence AnalysisABSTRACT
BACKGROUND AND PURPOSE: (+/-)-SB 209670, a potent nonpeptide endothelin (ET) receptor antagonist, was used to investigate the potential role of ET in cerebral vasospasm associated with subarachnoid hemorrhage. METHODS: The effects of (+/-)-SB 209670 were evaluated in isolated segments of canine posterior cerebral arteries in vitro, vascular smooth muscle cells in culture, and in the canine two-hemorrhage model of delayed cerebral vasospasm in vivo. RESULTS: In the canine basilar and anterior spinal arteries, (+/-)-SB 209670 caused a dose-related inhibition of contractile responses mediated by ET (KB = 4.6 nmol/L and apparent KB = 2.7 nmol/L, respectively). The effects of (+/-)-SB 209670 were mediated by inhibition of ETA receptors since the ETB selective agonist sarafotoxin 6c did not contract these posterior cerebral vessels. (+/-)-SB 209670 also produced a concentration-dependent inhibition (IC50 = 1 nmol/L) of the mitogenic response induced by ET-1 in vascular smooth muscle cell culture. In the canine model of delayed cerebral vasospasm, animals received intracisternal vehicle (saline) or (+/-)-SB 209670 (360 +/- 10 micrograms/d) via osmotic minipump for 7 days. On day 7, the cross-sectional areas in the (+/-)-SB 209670 group were significantly greater than those in the vehicle group in both the basilar artery (68% versus 27%) and anterior spinal artery (78% versus 38%). No differences in blood pressure or heart rate were noted in the two groups, and the vasospasm in the vehicle group did not differ from that of historic controls in this model. CONCLUSIONS: The results suggest that ET plays a significant role in the development of delayed cerebral vasospasm via an interaction with ETA receptors. Furthermore, ETA receptor antagonists may represent a novel therapeutic approach to the treatment of subarachnoid hemorrhage.
Subject(s)
Cerebrovascular Circulation/drug effects , Endothelin Receptor Antagonists , Endothelins/pharmacology , Indans/pharmacology , Ischemic Attack, Transient/physiopathology , Subarachnoid Hemorrhage/physiopathology , Animals , Arteries/drug effects , Basilar Artery/drug effects , Cells, Cultured , Cerebral Arteries/drug effects , Disease Models, Animal , Dogs , Dose-Response Relationship, Drug , Endothelins/agonists , Endothelins/antagonists & inhibitors , Indans/administration & dosage , Ischemic Attack, Transient/etiology , Ischemic Attack, Transient/prevention & control , Male , Mitogens , Muscle, Smooth, Vascular/drug effects , Spinal Cord/blood supply , Subarachnoid Hemorrhage/complications , Vasoconstriction/drug effects , Vasoconstrictor Agents/pharmacology , Viper Venoms/pharmacologyABSTRACT
A novel epoxide, in addition to eight known diterpenes, has been isolated from a marine brown alga of the genus Dictyota. The structures of these compounds were established by the interpretation and comparison of spectral data with literature data. Most of the isolates demonstrated vasopressin receptor antagonist activity in vitro with the new epoxide being the most active of the diterpenes tested.
Subject(s)
Diterpenes/isolation & purification , Epoxy Compounds/isolation & purification , Phaeophyceae/chemistry , Receptors, Vasopressin/drug effects , Animals , Diterpenes/chemistry , Diterpenes/pharmacology , Epoxy Compounds/chemistry , Epoxy Compounds/pharmacology , In Vitro Techniques , Magnetic Resonance Spectroscopy , Molecular Structure , Rats , Rats, Sprague-DawleyABSTRACT
To ascertain the extent and organization of the germ-line human T-cell receptor (TCR) beta-chain gene repertoire, beta-chain variable region (V beta) genes were mapped by pulsed-field gel electrophoresis, cosmid cloning, and in situ hybridization. Probes derived from the 24 known V beta families were mapped to a total of six Sfi I fragments in DNA samples from multiple individuals representing all possible haplotypes of TCR V- and C (constant)-region insertion/deletion-related polymorphisms. Four of the Sfi I fragments were linked to one another to develop an extended map of the TCR beta-chain gene complex previously localized to chromosome 7q35. The remaining two Sfi I fragments, containing 6 V beta genes, could not be linked to the TCR beta-chain gene complex. Using human-hamster somatic cell hybrids and in situ hybridization, these orphon genes were localized to chromosome 9p. Nucleotide sequences of the orphon V beta genes, derived from cosmid clones, were 93-97% identical to V beta genes in the TCR beta-chain gene complex. Open reading frames in three of the orphon V beta genes were intact as were the recombination signal sequences. As expected, based on their orphon status, none of the V beta genes of chromosome 9 was detected in transcripts containing C beta. These results indicate that the functional germ-line V beta repertoire in humans is substantially (10%) smaller than previously estimated.
Subject(s)
Chromosomes, Human, Pair 7 , Chromosomes, Human, Pair 9 , Gene Rearrangement, beta-Chain T-Cell Antigen Receptor , Multigene Family , Receptors, Antigen, T-Cell, alpha-beta/genetics , Animals , Base Sequence , Blotting, Southern , Cloning, Molecular , Cosmids , DNA/genetics , DNA/isolation & purification , Gene Deletion , Gene Library , Genes, Immunoglobulin , Genotype , Humans , Hybrid Cells , In Situ Hybridization , Karyotyping , Mice , Molecular Sequence Data , Oligodeoxyribonucleotides , Polymerase Chain Reaction/methods , Restriction Mapping , Transcription, GeneticABSTRACT
Amphotericin B administration to 8 dogs (1 mg/kg.d, i.v.) for 3 days resulted in significant (P less than .01) reductions in 24-hr creatinine clearance. SK&F R-105058 is an N-ethyl carbamate ester prodrug of the selective DA1 receptor agonist, fenoldopam, which, on oral administration to dogs, results in sustained plasma levels of the renal vasodilator, fenoldopam. Treatment of 6 dogs with SK&F R-105058 (10 mg/kg p.o. b.i.d.) resulted in a significant attenuation of the amphotericin B-induced reductions in creatinine clearance observed on days 2 and 3 after initiation of amphotericin treatment. However, the increase in urine flow and fractional sodium excretion induced by amphotericin B was not altered by SK&F R-105058 treatment. Subsequent histological analysis of the kidneys demonstrated lesions consisting of multifocal tubular degeneration, necrosis and mineralization of mostly distal tubules. Quantitation of tubular lesions indicated that SK&F R-105058 significantly reduced the morphological changes induced by amphotericin B. The data indicate that administration of a fenoldopam prodrug can delay amphotericin B-induced reductions in glomerular filtration rate in the dog.
Subject(s)
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/analogs & derivatives , Amphotericin B/antagonists & inhibitors , Benzazepines/pharmacology , Carbamates/pharmacology , Kidney/drug effects , Prodrugs/pharmacology , 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine/pharmacology , Amphotericin B/toxicity , Animals , Creatinine/metabolism , Diuresis/drug effects , Dogs , Fenoldopam , Kidney Tubules/drug effects , Kidney Tubules/pathology , Male , Natriuresis/drug effectsABSTRACT
Polymorphism of human T cell antigen receptor (TCR)alpha genes was detected by restriction fragment length polymorphism (RFLP). Individual TCR alpha gene segments showed limited polymorphism in that few restriction enzymes revealed polymorphism in genomic DNA samples and when RFLP were detected only two or three allelic forms were observed. A rabbit TCR alpha cDNA clone (VJR5) detected polymorphism in human DNA samples digested with PvuII or MspI. In order to characterize the human V alpha genes detected by the rabbit probe, genomic clones hybridizing with the VJR5 probe were isolated and characterized. A probe derived from a human genomic clone (HUTAVR5) hybridized with some but not all fragments detected by the rabbit VJR5 probe. The data suggest that the rabbit probe hybridized with two distinct human TCR alpha V genes and that polymorphism of each gene was detectable by only one restriction enzyme. In contrast to the limited polymorphism of TCR alpha genes detected by individual markers, extensive heterogeneity of TCR alpha genes was observed in the combination of markers present in haplotypes. Six RFLP were used as TCR alpha markers to define haplotypes in 20 parents and 53 offspring from 10 families and 17 different combinations of markers were observed. The observation that TCR alpha haplotypes include numerous combinations of markers that individually show limited polymorphism suggests that recombination may occur frequently within the TCR alpha gene complex.
Subject(s)
Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor/genetics , Genes, MHC Class II/genetics , Polymorphism, Restriction Fragment Length , Receptors, Antigen, T-Cell/genetics , Animals , DNA , DNA Probes , Genetic Markers , Haplotypes/genetics , Humans , Nucleic Acid Hybridization , Rabbits , Receptors, Antigen, T-Cell, alpha-beta , Recombination, Genetic , Restriction MappingABSTRACT
The numbers of children under 5 years in South Glamorgan admitted to hospital because of accidental poisoning have been analysed for 1980-4. There has been no significant fall in those taking solid dose, prescribable medications since the voluntary agreement between the government and the pharmaceutical profession in 1981 on child resistant containers. Most children still take these poisons from containers of an ordinary, non-child resistant type. Aspirin poisoning has remained at the same low level since the introduction of regulations on child resistant containers in 1976, but there has been a rise in paracetamol liquid poisoning largely due to one preparation. The advent of 'original pack' dispensing in 1987-8 provides an ideal opportunity to ensure that child resistant containers are used for all medications that are toxic if taken by children.
Subject(s)
Drug Packaging , Poisoning/prevention & control , Child, Preschool , Hospitalization , Humans , Infant , Poisoning/epidemiology , WalesSubject(s)
Alkylating Agents/pharmacology , Busulfan/pharmacology , L Cells/drug effects , Sulfonic Acids/pharmacology , Alkylation , Animals , Chromatography, Paper , Chromatography, Thin Layer , DNA/metabolism , Dose-Response Relationship, Drug , Ethers/pharmacology , Guanine Nucleotides , Guanosine , Hydrogen-Ion Concentration , Isotope Labeling , L Cells/metabolism , Methane/pharmacology , Mice , Nucleic Acid Conformation , Nucleic Acid Denaturation , Nucleic Acid Renaturation , RNA/metabolism , TritiumABSTRACT
1. Glyceride biosynthesis from glycerol phosphate and [1-(14)C]palmitate was studied in liver homogenates of rats that were fed ad libitum or starved for 36-40hr. The changes in enzyme activity were related to total DNA content or total liver homogenate as these were found to be equivalent and to be the most meaningful parameters. 2. In liver homogenates from fed rats, labelled palmitate was incorporated mainly into phosphatidate (58% of the total incorporation into lipids), diglycerides (25%) and triglycerides (16%), whereas monoglycerides, cholesterol esters and phospholipids other than phosphatidate were labelled only to a small extent. Addition of particle-free supernatant to full homogenates increased the total incorporation of palmitate by 45% and the pattern of incorporation altered to 53% incorporated into triglycerides, 24% into diglycerides and 17% into phosphatidate. This result suggested that, in liver homogenates, phosphatidate phosphohydrolase (EC 3.1.3.4) may be rate-limiting in the biosynthesis of glycerides via the glycerol phosphate pathway. 3. Upon starvation, the amount of palmitate incorporated per liver into total phospholipids plus glycerides was decreased to between 68% and 75% of that observed with fed animals. In homogenates from fed animals 41-44% of the labelled phospholipids plus glycerides was in glycerides; this value increased to between 63% and 75% with starved rats. Of the palmitate incorporated into total phospholipids, between 85% and 86% was found in phosphatidate, independent of the nutritional state of the animal. The ratio of palmitate incorporated into triglycerides/diglycerides rose from 0.7, obtained with fed rats, to 1.0 with starved animals. 4. These results indicate that starvation caused a decrease in the activity (per total liver) of acyl-CoA-glycerol phosphate acyltransferase(s) (EC 2.3.1.15) and an increase in the activity of acyl-CoA-diglyceride acyltransferase (EC 2.3.1.20). The largest change, however, seemed to be related to the increased activity of the phosphatidate phosphohydrolase in the particle-free supernatant. 5. The latter enzyme was assayed in the particle-free supernatant with membrane-bound phosphatidate as substrate. In starvation, the activity per total liver was increased to between 130% and 190% and the specific activity to between 180% and 320% of the values for fed rats.